Enterprise Tech Ecosystem Series: Bayer AG 2026

Bayer AG (Bayer) is a life science company that engages in the discovery, development, manufacturing, and commercialization of pharmaceuticals, consumer health products, and crop science solutions. Its major products include high-value seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, prescription products, diagnostic imaging equipment, and over-the-counter medicines, among others. Bayer's products serve a wide range of customers, including patients, wholesalers, pharmacies and pharmacy chains, supermarkets, online retailers, and other large and small retailers, hospitals, and farmers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East.

The report provides information and insights into Bayer's tech activities, including:

• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships, product launches, investments, and acquisitions.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets and major ICT contracts.

Report Scope

• The report provides insights into company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Reasons to Buy

• Gain insights into Bayer's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches, partnerships, investments, and acquisitions.